Shanghai Junshi Biosciences Co., Ltd. (SHA:688180)
China · Delayed Price · Currency is CNY 34.90
-0.19 (-0.54%)
At close: Feb 6, 2026
SHA:688180 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -949.86 | -1,281 | -2,283 | -2,386 | -720.91 | -1,669 |
Depreciation & Amortization | 298.65 | 298.65 | 315.4 | 293.65 | 248.98 | 146 |
Other Amortization | 28.42 | 28.42 | 17.12 | - | 15.93 | 8.34 |
Loss (Gain) From Sale of Assets | -12.78 | -12.78 | -29.41 | -27.01 | -0.81 | -1.86 |
Asset Writedown & Restructuring Costs | 0.94 | 0.94 | 0.52 | 9.03 | 0.03 | -45.31 |
Loss (Gain) From Sale of Investments | 71.23 | 71.23 | 75.19 | - | -65.75 | 5.62 |
Loss (Gain) on Equity Investments | - | - | - | 71.03 | - | - |
Stock-Based Compensation | - | - | - | 91.91 | - | - |
Provision & Write-off of Bad Debts | -14.67 | -14.67 | 18.34 | 0.05 | 0.36 | -0.34 |
Other Operating Activities | 428.97 | -10.02 | -178.56 | -515.11 | 7.55 | 37.77 |
Change in Accounts Receivable | 54.21 | 54.21 | -314.42 | 971.48 | -770.56 | -482.17 |
Change in Inventory | -159.27 | -159.27 | -32.45 | -136.39 | -154.82 | -166.99 |
Change in Accounts Payable | -415.29 | -415.29 | 262.67 | -479.57 | 702.33 | 685.97 |
Change in Unearned Revenue | - | - | - | 1.05 | - | - |
Change in Other Net Operating Assets | -10.67 | -10.67 | 19.01 | 330.62 | 195.05 | 30.73 |
Operating Cash Flow | -663.78 | -1,434 | -2,005 | -1,775 | -605.05 | -1,456 |
Capital Expenditures | -579.78 | -690.99 | -832.57 | -383.1 | -901.77 | -580.47 |
Sale of Property, Plant & Equipment | 8.02 | 1.87 | 4.1 | 0 | 0.01 | - |
Cash Acquisitions | - | - | - | 2.22 | - | - |
Sale (Purchase) of Intangibles | - | - | - | -10.85 | - | - |
Investment in Securities | -162.1 | -247.76 | -207.9 | -104.24 | -1,045 | -172.13 |
Other Investing Activities | 15.8 | 44.1 | 103.19 | 28.35 | 28.95 | 12.19 |
Investing Cash Flow | -718.06 | -892.78 | -933.19 | -467.62 | -1,918 | -740.41 |
Long-Term Debt Issued | - | 2,307 | 977.1 | 840.36 | 500 | 374.24 |
Long-Term Debt Repaid | - | -1,214 | -533.78 | -154.26 | -828.36 | -426.76 |
Net Debt Issued (Repaid) | 724.21 | 1,093 | 443.32 | 686.1 | -328.36 | -52.52 |
Issuance of Common Stock | 939.58 | - | 152.59 | 3,812 | 2,122 | 4,527 |
Repurchase of Common Stock | -4 | -4 | -26.89 | - | - | - |
Common Dividends Paid | -92.23 | -73.79 | -38.23 | - | -16.69 | -43.16 |
Other Financing Activities | 98.13 | 7.81 | 181.03 | 144.64 | 889 | -17.68 |
Financing Cash Flow | 1,666 | 1,023 | 711.83 | 4,643 | 2,666 | 4,414 |
Foreign Exchange Rate Adjustments | 11.49 | 12.01 | 7.55 | 92.27 | -23.23 | -45.77 |
Net Cash Flow | 295.34 | -1,291 | -2,219 | 2,492 | 119.61 | 2,171 |
Free Cash Flow | -1,244 | -2,125 | -2,838 | -2,158 | -1,507 | -2,037 |
Free Cash Flow Margin | -50.08% | -109.06% | -188.85% | -148.50% | -37.44% | -127.71% |
Free Cash Flow Per Share | -1.25 | -2.16 | -2.88 | -2.35 | -1.69 | -2.48 |
Cash Interest Paid | - | - | - | 25.55 | - | - |
Cash Income Tax Paid | 74.43 | 78.6 | -65.42 | 107.13 | -43.19 | -25.64 |
Levered Free Cash Flow | -757.18 | -1,104 | -2,116 | -1,310 | -1,174 | -1,394 |
Unlevered Free Cash Flow | -714.48 | -1,072 | -2,098 | -1,292 | -1,160 | -1,375 |
Change in Working Capital | -514.68 | -514.68 | 59.85 | 687.19 | -90.44 | 62.01 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.